% | $
Quotes you view appear here for quick access.

Biogen Inc. Message Board

  • b4548181 b4548181 May 17, 1998 6:37 PM Flag

    Barrons article

    thanks hniman for a great post. I read the
    article and it indicates a good short and medium term out
    look for IDEC. It mentions all the current trials
    going on and says IDEC has a strong cash position
    compared to its rivals. It also says IDEC gets an
    escalating % of profits from its partnership with Genetech
    on its new


    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Hi,
      why is idph down today , after the news ? Does it look that bad ?


      • 2 Replies to cements
      • In my opinion there are several factors
        the stock in the short term:
        1. traders playing
        the Oncology meeting - I have noticed
        price movements in anticipation of positive
        then a sell off on the "news"
        2. Concern about
        Coulter's drug
        3. I heard that a co at the meeting was
        going to
        discuss dna-cellular treatments for
        Lymphoma. This could
        have the uninformed thinking that
        the monoclonal
        antibody treatments may become
        obsolete in the near term.
        I personally think Idec is
        a buy-analysts think
        it's a buy. I'm ignoring
        the noise, though the
        stock price volitility is

      • My server says the news about Rituxan having a
        97% success rate was reported after the close. Is
        that the news u are speaking of, or are u referring to
        the positive article in Barrons? It makes no sense
        either way why the stock isnt soaring now. When two
        major positive stories appear in one day and the stocks
        goes DOWN 1 1/2 concerns me. It was UP 1 1/2 earlier
        in the day so it dropped 3 points from that high!
        What happened?

290.78+0.13(+0.04%)Oct 24 4:00 PMEDT